QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2021    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Modeling very high electron heating by radio frequency waves on EAST 期刊论文 NUCLEAR FUSION, 2021, 卷号: 61 作者:  Huang, Yueheng;  Xiang, Nong;  Chen, Jiale;  Ma, Longhao;  Li, Erzhong 收藏  |  浏览/下载：47/0  |  提交时间：2021/09/06 EAST  integrated modeling  LHW  ECW  high electron heating   Investigation of Alfven eigenmodes and energetic particle modes in EAST with neutral beam injection 期刊论文 NUCLEAR FUSION, 2021, 卷号: 61 作者:  Xu, Liqing;  Shen, Wei;  Ren, Zhenzhen;  Zhou, Tianfu;  Wang, Yifeng 收藏  |  浏览/下载：56/0  |  提交时间：2021/08/31 Alfven eigenmodes  EAST  frequency chirping  fast ions  wave-particle resonance  energetic particle modes   Numerical and Experimental Evaluation of Shine-Through Loss and Beam Heating Due to Neutral Beam Injection on EAST 期刊论文 CHINESE PHYSICS LETTERS, 2021, 卷号: 38 作者:  Wang, Jin-Fang;  Li, Ying-Ying;  Wu, Bin;  Chen, Yu-Qing;  Li, Jun 收藏  |  浏览/下载：33/0  |  提交时间：2021/08/31 The preliminary efficacy of KN026 (Anti-HER2 BsAb) in advanced gastric and gastroesophageal junction cancer patients with HER2 expression. 期刊论文 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Xu, Jianming;  Zhang, Yun;  Wu, Jun;  Xu, Nong;  Ying, Jieer 收藏  |  浏览/下载：22/0  |  提交时间：2022/01/10 Investigation of Alfvén eigenmodes and energetic particle modes in EAST with neutral beam injection 期刊论文 Nuclear Fusion, 2021, 卷号: 61 作者:  Xu,Liqing;  Shen,Wei;  Ren,Zhenzhen;  Zhou,Tianfu;  Wang,Yifeng 收藏  |  浏览/下载：50/0  |  提交时间：2021/06/21 Alfvén eigenmodes  EAST  frequency chirping  fast ions  wave-particle resonance  energetic particle modes   Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文 CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021 作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan 收藏  |  浏览/下载：29/0  |  提交时间：2021/03/15 Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer   Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective 期刊论文 TUMORI JOURNAL, 2021 作者:  Tong, Ying-hui;  Ding, Hai-ying;  Xin, Wen-xiu;  Zhong, Li-ke;  Xu, Gao-qi 收藏  |  浏览/下载：38/0  |  提交时间：2021/08/30 Cost-effectiveness  durvalumab  etoposide plus platinum chemotherapy  first-line treatment  SCLC